Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gene therapy and other novel treatment approaches for Charcot-Marie-Tooth disease
Chiara Pisciotta, Davide Pareyson
Neuromuscular Disorders (2023) Vol. 33, Iss. 8, pp. 627-635
Closed Access | Times Cited: 24

Showing 24 citing articles:

Therapeutic potential of siRNA PMP22-SQ nanoparticles for Charcot-Marie-Tooth 1A neuropathy in rodents and non-human primates
Suzan Boutary, Guy Khalaf, Yosef Landesman, et al.
International Journal of Pharmaceutics (2025), pp. 125234-125234
Open Access | Times Cited: 1
Gene therapies for CMT neuropathies: from the bench to the clinic
Marina Stavrou, Kleopas A. Kleopa
Current Opinion in Neurology (2024) Vol. 37, Iss. 5, pp. 445-454
Closed Access | Times Cited: 4
Schwann Cells in Neuromuscular Disorders: A Spotlight on Amyotrophic Lateral Sclerosis
Kathryn R. Moss, Smita Saxena
Cells (2025) Vol. 14, Iss. 1, pp. 47-47
Open Access
Disease Progression in Charcot‐Marie‐Tooth Disease Type 4B (CMT4B) Associated With Mutations in Myotubularin‐Related Proteins 2 and 13
Alessandro Bertini, Mary M. Reilly, Chiara Pisciotta, et al.
European Journal of Neurology (2025) Vol. 32, Iss. 2
Open Access
Twelve‐month change in quantitative MRI calf muscle fat fraction in CMT1A predicts clinical change over 4 years
Matthew R. Evans, Hamza A. Salhab, Christopher D. J. Sinclair, et al.
Annals of Clinical and Translational Neurology (2025)
Open Access
Charcot-marie-tooth disease: a review of clinical developments and its management - What’s new in 2025?
Amedeo De Grado, Paola Saveri, Paola Saveri, et al.
Expert Review of Neurotherapeutics (2025)
Closed Access
From in vivo models to in vitro bioengineered neuromuscular junctions for the study of Charcot-Marie-Tooth disease
Camille Scherrer, Camille Loret, Nicolas Védrenne, et al.
Journal of Tissue Engineering (2025) Vol. 16
Open Access
Cannabinoids, Endocannabinoids, and Synthetic Cannabimimetic Molecules in Neuromuscular Disorders
Fabio Arturo Iannotti
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 238-238
Open Access | Times Cited: 8
Will new investigational drugs change the way we treat Charcot-Marie-Tooth disease?
Amedeo De Grado, Chiara Pisciotta, Paola Saveri, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 7, pp. 653-656
Open Access | Times Cited: 1
Navigating the Landscape of CMT1B: Understanding Genetic Pathways, Disease Models, and Potential Therapeutic Approaches
Mary Kate McCulloch, Fatemeh Mehryab, Afrooz Rashnonejad
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9227-9227
Open Access | Times Cited: 1
Gene Therapy in Neurological Diseases
Mehmet Ufuk Aluçlu
Gene Therapy (2024), pp. 93-105
Closed Access | Times Cited: 1
Physical exercise halts further functional decline in an animal model for Charcot–Marie–Tooth disease 1X at an advanced disease stage
Dennis Klein, Maria Grijalva Yépez, Rudolf Martini
Journal of the Peripheral Nervous System (2024)
Open Access | Times Cited: 1
A fully human IgG1 antibody targeting connexin 32 extracellular domain blocks CMTX1 hemichannel dysfunction in an in vitro model
Abraham Tettey‐Matey, Viola Donati, Chiara Cimmino, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
A Role of Inflammation in Charcot–Marie–Tooth Disorders—In a Perspective of Treatment?
Joanna Kamińska, Andrzej Kochański
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 15-15
Open Access | Times Cited: 1
In Vivo Ultrafast Doppler Imaging Combined with Confocal Microscopy and Behavioral Approaches to Gain Insight into the Central Expression of Peripheral Neuropathy in Trembler-J Mice
Mariana Martínez Barreiro, Lucía Vázquez Alberdi, Lucila De León, et al.
Biology (2023) Vol. 12, Iss. 10, pp. 1324-1324
Open Access | Times Cited: 2
Hereditary Motor Neuropathy
Jonathan De Winter, Jonathan Baets
Elsevier eBooks (2024)
Closed Access
Neuropatías Sensoriomotoras enenfermedad hereditaria Charcot Marie-Tooth tipo 1
Cristhian David Tomsich Romo Lerux, Elizabeth Jessenia Ponce Campoverde, Víctor Hugo Ramos Arias, et al.
Ciencia Latina Revista Científica Multidisciplinar (2024) Vol. 8, Iss. 1, pp. 11719-11730
Open Access
Charcot-Marie-Tooth Disease With Leukodystrophy: An Atypical Presentation
Ali Almarzooqi
Cureus (2024)
Open Access
Hidden hearing loss in a Charcot-Marie-Tooth type 1A mouse model
Luis R. Cassinotti, Lingchao Ji, M. Caroline Yuk, et al.
JCI Insight (2024) Vol. 9, Iss. 19
Open Access
Efficient data labeling strategies for automated muscle segmentation in lower leg MRIs of Charcot-Marie-Tooth disease patients
Seung‐Ah Lee, Hyun Su Kim, Ehwa Yang, et al.
PLoS ONE (2024) Vol. 19, Iss. 9, pp. e0310203-e0310203
Open Access
Current Treatment Methods for Charcot–Marie–Tooth Diseases
Hongxian Dong, Boquan Qin, Hui Zhang, et al.
Biomolecules (2024) Vol. 14, Iss. 9, pp. 1138-1138
Open Access
Photocleavable Guide crRNAs for a Light-Controllable CRISPR/Cas9 System
Lubov Sakovina, Ivan P. Vokhtantsev, Е. А. Ахметова, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12392-12392
Open Access
Demystification and feasibility of CRISPR technology and gene editing in African laboratories
Mohamed Jèmaà
Biology Open (2023) Vol. 12, Iss. 10
Open Access
Hidden hearing loss in hereditary demyelinating neuropathies: insights from Charcot-Marie-Tooth mouse models
Luis R. Cassinotti, Lingchao Ji, M. Caroline Yuk, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top